New muscle drug JUV-161 tested in humans for first time
Knowledge-focused
Ongoing
This early-stage study is testing a new drug, JUV-161, in 72 healthy adults to see if it is safe and how the body processes it. It is the first time this drug is given to humans. The results will help plan future studies in people with muscle diseases like myotonic dystrophy.
Phase: PHASE1 • Sponsor: Juvena Therapeutics • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC